Early-stage biotech developing oral microbiome therapies.
Industry: Health Care
First Day Return: -5.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/11/2019 |
Offer Price | $15.00 |
Price Range $20.00 - $22.00 | |
Offer Shares (mm) | 5.0 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/27/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Lexington, MA, United States |
Founded | 2015 |
Employees at IPO | 118 |
Website www.kaleido.com |